References
Ahn YS, Harrington WJ (1977) Treatment of idiopathic thrombocytopenic purpura. Annu Rev Med 28: 299
Ahn YS, Harrington WJ (1980) Clinical use of macrophage inhibitors. Adv Intern Med 25: 453
Ahn YS, Harrington WJ, Seelman RC, Eytel C (1974) Vincristine therapy of idiopathic and secondary thrombocytopenias. N Engl J Med 291: 376
Ahn YS, Byrnes JJ, Harrington WJ, Cayer ML, Smith DS, Brunskill DE, Pall LM (1978) The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. N Engl J Med 298:1101
Ahn YS, Harrington WJ, Byrnes JJ, Pestana JB (1978) Slow infusion vinca alkaloids in the treatment of refractory ITP. Clin Res 26: 795a
Ahn YS, Harrington WJ, Mylvaganam R, Allan LM, Pall LM (to be published) Slow infusion of vinca alkaloids in treatment of idiopathic thrombocytopenic purpura. Ann Intern Med
Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG (1983) The use of danazol in idiopathic thrombocytopenia purpura. N Engl J Med
Ahn YS, Harrington WJ, Mylvaganam R, Chua L, Otoya J, Pall LM. Danazol therapy restores helper/suppressor (T4/T8) ratios in patients with idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia Blood 62 (suppl) 1983 (in press)
Bierling P, Farcet JP, Dvedari N (1982) Gammaglobulin for idiopathic thrombocytopenic purpura. N Engl J Med 307: 1150
Bouroncle BA, Doan CA (1966) Refractory idiopathic thrombocytopenic purpura treated with Imuran. N Engl J Med 275: 630
Branda RE, Tate DY, McCullough JJ, Jacob HS (1978) Plasma exchange in the treatment of fulminant (autoimmune) thrombocytopenic purpura. Lancet 1: 688
Brennan MF, Rappaport JM, Moloney WC, Wilson RE et al. (1975) Correlation between response to corticosteroids and splenectomy for adult idiopathic thrombocytopenic purpura. Am J Surg 129:490
Broome CV, Facklam RR, Fraser DW (1980) Pneumococcal disease after pneumococcal vaccination: alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303: 549
Watson-Williams EJ, Macpherson AIS, Davidson S (1958) Treatment of idiopathic thrombocytopenic purpura. Lancet 275: 221
Carpenter AF, Wintrobe MM, Fuller EA, Haut A, Cartwright G (1959) Treatment of idiopathic thrombocytopenic purpura. JAMA 171: 1911
Cohen P, Gardner FH (1961) Thrombocytopenic effect of sustained high-dosage prednisone therapy in thrombocytopenic purpura. N Engl J Med 265: 611
Defino SM, Lachant NA, Kirshner JJ, Gottlieb AJ (1980) Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 69: 430
Doan CA, Bouroncle BA, Wiseman BK (1960) Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med 53: 861
Fehr J, Hoffman V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high dose intravenous gammaglobulin. N Engl J Med 306: 1254
Finch SC, Castro O, Cooper M, Covey W, Erichson R, McPhedran P (1974) Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am J Med 56: 4
Finland M (1961) Serious infections in splenectomized children. Pediatrics 27: 689
Harker LA (1970) Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol (1916) 19: 95
Harrington WJ, Ahn YS. Unpublished observations
Harrington WJ, Arimura G (1961) Immune reactions of platelets. Henry Ford Hosp. Symp. Blood platelets. Little Brown, Boston, p 659
Harrington WJ, Halloran MJ (1960) Studies on steroid binding by mammaliam platelets. Proc VIII Intern Congr Hematol 1960, p 1750
Harrington WJ, Minnich V, Hollingsworth JW, Moore CV (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38: 1
Harrington WJ, Sprague CC, Minnich V, Moore CV, Ahlvin R, Dubach R (1953) Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med 38: 433
Harrington WJ, Minnich V, Arimura G (1956) The autoimmune thrombocytopenias. Prog Hematol 1: 166
Harrington WJ, Ahn YS, So AG, Ayub J, Simon S, Pall LM (1982) Danazol therapy of autoimmune thrombocytopenias. Blood 60: 186a
Imbach P, Barandum S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228
Junghans RP, Ahn YS, Mylvaganam R (1983) High dose intravenous gammaglobulin to suppress alloimmune destruction of donor platelets. Clin Res 31: 482A
Karpatkin S (1980) Autoimmune thrombocytopenic purpura. Blood 56: 329
Kaznelson P (1916) Verschwinden der hämorrhagischen Diathese bei einem Falle von „essentieller Thrombopenie” (Frank) nach Milzextirpation. Splenogene thrombolytische purpura. Wien Klin Wochenschr 29: 1451
Laros RK, Penner JA (1971) “Refractory” thrombocytopenia purpura treated successfully with cyclophosphamide. JAMA 215: 445
Marder VJ, Nusbacher J, Anderson FW (1981) One year follow-up of plasma exchange therapy in 14 patients with thrombocytopenic purpura. Transfusion 21: 291
McMillan R (1981) Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304: 1135
Melo J, Harrington WJ, Ahn YS, Collin AS (1981) Colchicine therapy of idiopathic thrombocytopenic purpura (ITP). Blood 58 (Suppl 1): 200A
Meyers MC (1961) Results of treatment in 71 patients with idiopathic thrombocytopenic purpura. Am J Med Sci 242: 295
Michalski JP, McCombs CC, Roubinian JR, Talal N (1983) Effect of androgen therapy on survival and suppressor cell activity in aged NZB/NZW Fl hybrid mice. Clin Exp Immunol 52: 229
Mueller-Eckhardt C, Kuenzlen E, Thilo-Korner D, Thilo-Körner, Pralle H (1983) High-dose intravenous immunoglobulin for post-transfusion purpura. N Engl J Med 308: 287
Robson HN, Duthie JJR (1950) Capillary resistance and adrenocortical activity. Br Med J 2: 971
Shulman NR, Marder VJ, Weinrach RS (1965) Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic thrombocytopenic purpura: physiologic, serologic, and isotopic studies. Ann NY Acad Sci 124: 499
Strother SV, Zuckerman KS, LoBuglio AF (1982) Colchicine therapy of refractory immune thrombocytopenia. Blood 60 (Suppl 1): 193A
Sussman LN (1967) Azathioprine in refractory idiopathic thrombocytopenic purpura. JAMA 202: 259
Thompson RC, Moore RA, Hess CE, Wheby MS, Leavell BS (1972) Idiopathic thrombocytopenic purpura: long-term results of treatment and the prognostic significance of response to corticosteroids. Arch Intern Med 132: 380
Verheyden CN, Beart RW, Lifton MD, Phyliky RL (1978) Accessory splenectomy in management of recurrent idiopathic thrombocytopenic purpura. Mayo Clin Proc 53: 442
Verlin M, Laros RK, Penner J (1976) Treatment of refractory thrombocytopenic purpura with cyclophosphamide. Am J Hematol 1: 97
Viala JJ, Dechavanne M, Ville D (1975) Les épreuves radioisotopiques plaquetaires permettent-elles de meilleures indications de la splénectomie au cours du purpura thrombopénique idiopathique chronique? A propos de 50 observations. Lyon Med 234: 419
Weinerman B, Maxwell I, Hryniuk W (1974) Intermittent cyclosphamide treatment of autoimmune thrombocytopenia. Can Med Assoc J 16: 1100
Author information
Authors and Affiliations
Additional information
Supported by grants # 5R01 AM 25485 and # 5 M01 RR00261, by a Miami VA merit review award (0215-01) as well as by funds provided by the Mary Beth Weiss Research Fund, the Women's Cancer Association, the Steven Andrew de Young Leukemia Foundation, the H. Spencer Lichte Memorial Fund and the Crane Family Fund.
Rights and permissions
About this article
Cite this article
Ahn, Y.S., Harrington, W.J. & Mylvaganam, R. Immunosuppressant therapy of idiopathic thrombocytopenic purpura. Springer Semin Immunopathol 7, 35–42 (1984). https://doi.org/10.1007/BF01891778
Issue Date:
DOI: https://doi.org/10.1007/BF01891778